knowledge -WSS

knowledge

author：entertainment 2025-10-02 11:09:53 - browse：6934

Monica Bertagnolli -- Health Policy coverage from STAT — Monica Bertagnolli, the nominee to lead the National Institutes of Health Jeff Chiu/AP

Monica Bertagnolli, President Biden’s nominee to lead the National Institutes of Health, spent her confirmation hearing Wednesday stuck in the middle of Republicans’ and Democrats’ bickering over her agency’s role in high drug costs, ultimately refusing to commit to either party’s approach.

Bertagnolli similarly walked a line on government funding for gender-affirming care research and other hotly politicized health care issues, though she did stress that transgender youth are some of the country’s most vulnerable people.

The long-awaited hearing came months after Committee Chairman Bernie Sanders (I-Vt.) pledged to stall her confirmation process until Biden did more to address high drug prices, like an assurance that the NIH would insert reasonable pricing requirements into deals with commercial drugmakers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Illumina names Agilent executive as new CEO

hotspot

leisure time

WSS

STAT Summit: Meghan O’Rourke on making chronic illness visible

How to protect patients from sexual assault

ADCs take center stage as promising cancer treatments

The problems with dementia villages

Advances in CAR

UnitedHealth, Optum discontinue NaviHealth name

focus

knowledge

entertainment

Trump demands the U.S. pay no more for drugs than other countries … again

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Guidelines to prevent youth baseball injuries need more muscle

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Drug repurposing or repositioning? The language matters

Crinetics acromegaly drug succeeds in late

ChatGPT in medicine: STAT answers readers' burning questions

STAT Readout Newsletter: Biotech news today

Novavax promises a turnaround & Lilly roils the obesity market

ALS advocates say criticism of new drugs misses bigger picture

knowledge

Merck, Daiichi strike cancer drug pact worth up to $22 billion

STAT Readout Newsletter: Biotech news today

What American doctors can learn from their Israeli counterparts

STAT Summit: Ending the crisis of Black deaths in the U.S.

How to protect patients from sexual assault

UnitedHealth, Optum discontinue NaviHealth name

hotspot

leisure time

entertainment

hotspot